SOPH
SOPHiA GENETICS S.A.
NASDAQ · Healthcare · Medical - Healthcare Information Services · CH
$8.16
−1.75%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 6.55x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.35x
- Price / sales
- 8.06x
- Price / cash flow
- -16.69x
Enterprise value
- Enterprise value
- $648.4M
- EV / sales
- 7.52x
- EV / EBITDA
- -9.96x
- EV / EBIT
- -8.85x
- Market cap
- $694.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026